Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXZT2M
|
||||
Drug Name |
4-(5-{[2-(3-Fluoro-phenyl)-3-oxo-2,3,4,5-tetrahydro-1H-benzo[c]azepin-4-ylamino]-methyl}-imidazol-1-ylmethyl)-benzonitrile
|
||||
Synonyms |
CHEMBL166353
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C28H24FN5O
|
||||
Canonical SMILES |
Fc1cccc(c1)N2Cc3ccccc3CC(NCc4cncn4Cc5ccc(cc5)C#N)C2=O
|
||||
InChI |
InChI=1S/C28H24FN5O/c29-24-6-3-7-25(13-24)34-18-23-5-2-1-4-22(23)12-27(28(34)35)32-16-26-15-31-19-33(26)17-21-10-8-20(14-30)9-11-21/h1-11,13,15,19,27,32H,12,16-18H2
|
||||
InChIKey |
QKWVXFYKJWTMMF-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.